Coya Therapeutics (COYA) Assets Average (2023 - 2026)

Coya Therapeutics has disclosed Assets Average across 4 years of filings, most recently posting $50.3 million for Q2 2026.

• In Q2 2026, Assets Average rose 39.97% year-over-year to $50.3 million; the TTM figure through Jun 2026 stood at $50.3 million (up 39.97% YoY), while the FY2025 annual figure was $47.1 million, up 10.15% from the prior year.
• Assets Average came in at $50.3 million for Q2 2026 at Coya Therapeutics, down from $51.6 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $51.6 million in Q1 2026 to a low of $12.9 million in Q1 2023.
• Average Assets Average over 4 years is $34.1 million, with a median of $38.2 million recorded in 2024.
• Year-over-year, Assets Average jumped 204.7% in 2024 and decreased 13.24% in 2025.
• Over 4 years, Assets Average stood at $26.6 million in 2023, then jumped by 50.31% to $39.9 million in 2024, then gained by 2.62% to $41.0 million in 2025, then grew by 22.67% to $50.3 million in 2026.
• Per Business Quant data, the three most recent Assets Average figures were $50.3 million in Q2 2026, $51.6 million in Q1 2026, and $41.0 million in Q4 2025.